Trials / Conditions / Cryopyrin-Associated Periodic Syndromes

Cryopyrin-Associated Periodic Syndromes

7 registered clinical trials studyying Cryopyrin-Associated Periodic Syndromes — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide t NCT06974877	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Unknown	A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS) NCT03923140	Peking Union Medical College Hospital	Phase 2
Completed	Kineret CAPS Post Authorisation Study NCT02326376	Swedish Orphan Biovitrum	—
Completed	Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Peri NCT01576367	Novartis Pharmaceuticals	Phase 3
Completed	Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Peri NCT01302860	Novartis Pharmaceuticals	Phase 3
Completed	Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopy NCT00991146	Novartis Pharmaceuticals	Phase 3
Completed	Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial NCT00685373	Novartis	Phase 3